Fennec Pharmaceuticals (FENC) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$3000.0.
- Fennec Pharmaceuticals' Other Non Operating Income changed N/A to -$3000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was $3000.0, marking a year-over-year increase of 10468.75%. This contributed to the annual value of -$82000.0 for FY2024, which is 174000.0% down from last year.
- According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Other Non Operating Income is -$3000.0.
- Over the past 5 years, Fennec Pharmaceuticals' Other Non Operating Income peaked at $17000.0 during Q2 2025, and registered a low of -$38000.0 during Q1 2024.
- In the last 5 years, Fennec Pharmaceuticals' Other Non Operating Income had a median value of -$3000.0 in 2022 and averaged -$4066.7.
- In the last 5 years, Fennec Pharmaceuticals' Other Non Operating Income surged by 40000.0% in 2023 and then tumbled by 145000.0% in 2024.
- Fennec Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$1000.0 in 2021, then crashed by 300.0% to -$4000.0 in 2022, then skyrocketed by 150.0% to $2000.0 in 2023, then plummeted by 1450.0% to -$27000.0 in 2024, then soared by 88.89% to -$3000.0 in 2025.
- Its Other Non Operating Income was -$3000.0 in Q3 2025, compared to $17000.0 in Q2 2025 and $13000.0 in Q1 2025.